Emerging research highlights the underexplored role of gut neuropeptides in Parkinson’s disease, revealing new connections ...

The relationship between pathology in the brain and alterations in the gut microbiome could lead to therapies — even if it’s ...

April is Parkinson's disease awareness month. About one million Americans have Parkinson's and that figure could jump to 1.2 ...

Parkinson’s Disease is a neurodegenerative disorder that affected predominately the Dopamine-producing neurons in a specific ...

Parkinson’s Disease is commonly known as a movement disorder that affects the nervous system. But professionals say one ...

Currently, over 10 million people worldwide are living with Parkinson’s disease, a progressive neurodegenerative disorder ...

Parkinson’s disease is a progressive condition that damages parts of the brain over many years, caused by a loss of nerve ...

DelveInsight’s analysis forecasts Parkinson’s disease market growth due to the introduction of emerging therapies, expecting a rise in market size during the study period (2020–2034). The anticipated ...

In a first-of-its-kind human trial, researchers transplanted iPS-cell-derived dopaminergic progenitors into patients with ...